nach oben

Brain Structure and Function

Erschienen in:

17.08.2019 | Original Article

Group I metabotropic glutamate receptors in the primate motor thalamus: subsynaptic association with cortical and sub-cortical glutamatergic afferents

verfasst von: Gunasingh Jeyaraj Masilamoni, Yoland Smith

Erschienen in: Brain Structure and Function | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Abstract

Preclinical evidence indicates that mGluR5 is a potential therapeutic target for Parkinson’s disease and L-DOPA-induced dyskinesia. However, the mechanisms through which these therapeutic benefits are mediated remain poorly understood. Although the regulatory role of mGluR5 on glutamatergic transmission has been examined in various basal ganglia nuclei, very little is known about the localization and function of mGluR5 in the ventral motor and intralaminar thalamic nuclei, the main targets of basal ganglia output in mammals. Thus, we used immuno-electron microscopy to map the cellular and subcellular localization of group I mGluRs (mGluR1a and mGluR5) in the ventral motor and caudal intralaminar thalamic nuclei in rhesus monkeys. Furthermore, using double immuno-electron microscopy, we examined the subsynaptic localization of mGluR5 in relation to cortical and sub-cortical glutamatergic afferents. Four major conclusions can be drawn from these data. First, mGluR1a and mGluR5 are expressed postsynaptically on the plasma membrane of dendrites of projection neurons and GABAergic interneurons in the basal ganglia- and cerebellar-receiving regions of the ventral motor thalamus and in CM. Second, the plasma membrane-bound mGluR5 immunoreactivity is preferentially expressed perisynaptically at the edges of cortical and sub-cortical glutamatergic afferents. Third, the mGluR5 immunoreactivity is more strongly expressed in the lateral than the medial tiers of CM, suggesting a preferential association with thalamocortical over thalamostriatal neurons in the primate CM. Overall, mGluR5 is located to subserve powerful modulatory role of cortical and subcortical glutamatergic transmission in the primate ventral motor thalamus and CM.

Abe T, Sugihara H, Nawa H, Shigemoto R, Mizuno N, Nakanishi S (1992) Molecular characterization of a novel metabotropic glutamate receptor mGluR5 coupled to inositol phosphate/Ca2+ signal transduction. J Biol Chem 267(19):13361–13368PubMed

Amalric M (2015) Targeting metabotropic glutamate receptors (mGluRs) in Parkinson’s disease. Curr Opin Pharmacol 20:29–34. https://doi.org/10.1016/j.coph.2014.11.001 PubMedCrossRef

Ambrosi G, Armentero MT, Levandis G, Bramanti P, Nappi G, Blandini F (2010) Effects of early and delayed treatment with an mGluR5 antagonist on motor impairment, nigrostriatal damage and neuroinflammation in a rodent model of Parkinson’s disease. Brain Res Bull 82(1–2):29–38. https://doi.org/10.1016/j.brainresbull.2010.01.011 PubMedCrossRef

Andersson JD, Seneca N, Truong P, Wensbo D, Raboisson P, Farde L, Halldin C (2013) Palladium mediated (1)(1)C-cyanation and characterization in the non-human primate brain of the novel mGluR5 radioligand [(1)(1)C]AZD9272. Nucl Med Biol 40(4):547–553. https://doi.org/10.1016/j.nucmedbio.2012.12.012 PubMedCrossRef

Araque A, Parpura V, Sanzgiri RP, Haydon PG (1998) Glutamate-dependent astrocyte modulation of synaptic transmission between cultured hippocampal neurons. Eur J Neurosci 10(6):2129–2142PubMedCrossRef

Araque A, Sanzgiri RP, Parpura V, Haydon PG (1999) Astrocyte-induced modulation of synaptic transmission. Can J Physiol Pharmacol 77(9):699–706PubMedCrossRef

Barroso-Chinea P, Castle M, Aymerich MS, Perez-Manso M, Erro E, Tunon T, Lanciego JL (2007) Expression of the mRNAs encoding for the vesicular glutamate transporters 1 and 2 in the rat thalamus. J Comp Neurol 501(5):703–715. https://doi.org/10.1002/cne.21265 PubMedCrossRef

Batchelor AM, Garthwaite J (1997) Frequency detection and temporally dispersed synaptic signal association through a metabotropic glutamate receptor pathway. Nature 385(6611):74–77. https://doi.org/10.1038/385074a0 PubMedCrossRef

Battaglia G, Busceti CL, Molinaro G, Biagioni F, Storto M, Fornai F, Nicoletti F, Bruno V (2004) Endogenous activation of mGlu5 metabotropic glutamate receptors contributes to the development of nigro-striatal damage induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. J Neurosci 24(4):828–835. https://doi.org/10.1523/JNEUROSCI.3831-03.2004 PubMedPubMedCentralCrossRef

Baude A, Nusser Z, Roberts JD, Mulvihill E, McIlhinney RA, Somogyi P (1993) The metabotropic glutamate receptor (mGluR1 alpha) is concentrated at perisynaptic membrane of neuronal subpopulations as detected by immunogold reaction. Neuron 11(4):771–787PubMedCrossRef

Beczkowska IW, Gracy KN, Pickel VM, Inturrisi CE (1997) Detection of delta opioid receptor and N-methyl-D-aspartate receptor-like immunoreactivity in retinoic acid-differentiated neuroblastoma x glioma (NG108-15) cells. J Neurosci Res 47(1):83–89PubMedCrossRef

Berardi N, Morrone MC (1984) The role of gamma-aminobutyric acid mediated inhibition in the response properties of cat lateral geniculate nucleus neurones. J Physiol 357:505–523PubMedPubMedCentralCrossRef

Berg D, Godau J, Trenkwalder C, Eggert K, Csoti I, Storch A, Huber H, Morelli-Canelo M, Stamelou M, Ries V, Wolz M, Schneider C, Di Paolo T, Gasparini F, Hariry S, Vandemeulebroecke M, Abi-Saab W, Cooke K, Johns D, Gomez-Mancilla B (2011) AFQ056 treatment of levodopa-induced dyskinesias: results of 2 randomized controlled trials. Mov Disord 26(7):1243–1250. https://doi.org/10.1002/mds.23616 PubMedCrossRef

Blackstad TW, Karagulle T, Ottersen OP (1990) MORFOREL, a computer program for two-dimensional analysis of micrographs of biological specimens, with emphasis on immunogold preparations. Comput Biol Med 20(1):15–34PubMedCrossRef

Blethyn KL, Hughes SW, Toth TI, Cope DW, Crunelli V (2006) Neuronal basis of the slow (< 1 Hz) oscillation in neurons of the nucleus reticularis thalami in vitro. J Neurosci 26(9):2474–2486. https://doi.org/10.1523/JNEUROSCI.3607-05.2006 PubMedCrossRef

Blitz DM, Regehr WG (2005) Timing and specificity of feed-forward inhibition within the LGN. Neuron 45(6):917–928. https://doi.org/10.1016/j.neuron.2005.01.033 PubMedCrossRef

Brasnjo G, Otis TS (2001) Neuronal glutamate transporters control activation of postsynaptic metabotropic glutamate receptors and influence cerebellar long-term depression. Neuron 31(4):607–616PubMedCrossRef

Breysse N, Baunez C, Spooren W, Gasparini F, Amalric M (2002) Chronic but not acute treatment with a metabotropic glutamate 5 receptor antagonist reverses the akinetic deficits in a rat model of parkinsonism. J Neurosci 22(13):5669–5678. https://doi.org/10.1523/JNEUROSCI.22-13-05669.2002 PubMedPubMedCentralCrossRef

Breysse N, Amalric M, Salin P (2003) Metabotropic glutamate 5 receptor blockade alleviates akinesia by normalizing activity of selective basal-ganglia structures in parkinsonian rats. J Neurosci 23(23):8302–8309PubMedPubMedCentralCrossRef

Calzavara R, Zappala A, Rozzi S, Matelli M, Luppino G (2005) Neurochemical characterization of the cerebellar-recipient motor thalamic territory in the macaque monkey. Eur J Neurosci 21(7):1869–1894. https://doi.org/10.1111/j.1460-9568.2005.04020.x PubMedCrossRef

Chung W, Choi SY, Lee E, Park H, Kang J, Park H, Choi Y, Lee D, Park SG, Kim R, Cho YS, Choi J, Kim MH, Lee JW, Lee S, Rhim I, Jung MW, Kim D, Bae YC, Kim E (2015) Social deficits in IRSp53 mutant mice improved by NMDAR and mGluR5 suppression. Nat Neurosci 18(3):435–443. https://doi.org/10.1038/nn.3927 PubMedCrossRef

Coccurello R, Breysse N, Amalric M (2004) Simultaneous blockade of adenosine A2A and metabotropic glutamate mGlu5 receptors increase their efficacy in reversing Parkinsonian deficits in rats. Neuropsychopharmacology 29(8):1451–1461. https://doi.org/10.1038/sj.npp.1300444 PubMedCrossRef

Conn PJ, Pin JP (1997) Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 37:205–237. https://doi.org/10.1146/annurev.pharmtox.37.1.205 PubMedCrossRef

Conn PJ, Battaglia G, Marino MJ, Nicoletti F (2005) Metabotropic glutamate receptors in the basal ganglia motor circuit. Nat Rev Neurosci 6(10):787–798. https://doi.org/10.1038/nrn1763 PubMedCrossRef

Cox CL, Sherman SM (1999) Glutamate inhibits thalamic reticular neurons. J Neurosci 19(15):6694–6699PubMedCrossRef

Crunelli V, Haby M, Jassik-Gerschenfeld D, Leresche N, Pirchio M (1988) Cl−- and K+-dependent inhibitory postsynaptic potentials evoked by interneurones of the rat lateral geniculate nucleus. J Physiol 399:153–176PubMedPubMedCentralCrossRef

Drew GM, Mitchell VA, Vaughan CW (2008) Glutamate spillover modulates GABAergic synaptic transmission in the rat midbrain periaqueductal grey via metabotropic glutamate receptors and endocannabinoid signaling. J Neurosci 28(4):808–815. https://doi.org/10.1523/JNEUROSCI.4876-07.2008 PubMedPubMedCentralCrossRef

Dum RP, Li C, Strick PL (2002) Motor and nonmotor domains in the monkey dentate. Ann NY Acad Sci 978:289–301PubMedCrossRef

Errington AC, Di Giovanni G, Crunelli V, Cope DW (2011) mGluR control of interneuron output regulates feedforward tonic GABAA inhibition in the visual thalamus. J Neurosci 31(23):8669–8680. https://doi.org/10.1523/JNEUROSCI.0317-11.2011 PubMedPubMedCentralCrossRef

Evrard HC, Craig AD (2008) Retrograde analysis of the cerebellar projections to the posteroventral part of the ventral lateral thalamic nucleus in the macaque monkey. J Comp Neurol 508(2):286–314. https://doi.org/10.1002/cne.21674 PubMedCrossRef

Fujiyama F, Unzai T, Nakamura K, Nomura S, Kaneko T (2006) Difference in organization of corticostriatal and thalamostriatal synapses between patch and matrix compartments of rat neostriatum. Eur J Neurosci 24(10):2813–2824. https://doi.org/10.1111/j.1460-9568.2006.05177.x PubMedCrossRef

Galvan A, Kuwajima M, Smith Y (2006) Glutamate and GABA receptors and transporters in the basal ganglia: what does their subsynaptic localization reveal about their function? Neuroscience 143(2):351–375. https://doi.org/10.1016/j.neuroscience.2006.09.019 PubMedPubMedCentralCrossRef

Garber J, Barbee R, Bielitzki J, Clayton L, Donovan J, Hendriksen C, Kohn D, Lipman N, Locke P, Melcher J, Quimby F, Turner P, Wood G, Würbel H (2010) Guide for the care and use of laboratory animals. The National Academies Press, Washington, DC

Gasparini F, Bilbe G, Gomez-Mancilla B, Spooren W (2008) mGluR5 antagonists: discovery, characterization and drug development. Curr Opin Drug Discov Devel 11(5):655–665PubMed

Ge SN, Li ZH, Tang J, Ma Y, Hioki H, Zhang T, Lu YC, Zhang FX, Mizuno N, Kaneko T, Liu YY, Lung MS, Gao GD, Li JL (2014) Differential expression of VGLUT1 or VGLUT2 in the trigeminothalamic or trigeminocerebellar projection neurons in the rat. Brain Struct Funct 219(1):211–229. https://doi.org/10.1007/s00429-012-0495-1 PubMedCrossRef

Govindaiah G, Venkitaramani DV, Chaki S, Cox CL (2012a) Spatially distinct actions of metabotropic glutamate receptor activation in dorsal lateral geniculate nucleus. J Neurophysiol 107(4):1157–1163. https://doi.org/10.1152/jn.00401.2011 PubMedCrossRef

Govindaiah G, Wang T, Gillette MU, Cox CL (2012b) Activity-dependent regulation of retinogeniculate signaling by metabotropic glutamate receptors. J Neurosci 32(37):12820–12831. https://doi.org/10.1523/JNEUROSCI.0687-12.2012 PubMedPubMedCentralCrossRef

Graziano A, Liu XB, Murray KD, Jones EG (2008) Vesicular glutamate transporters define two sets of glutamatergic afferents to the somatosensory thalamus and two thalamocortical projections in the mouse. J Comp Neurol 507(2):1258–1276. https://doi.org/10.1002/cne.21592 PubMedCrossRef

Haass-Koffler CL, Goodyear K, Long VM, Tran HH, Loche A, Cacciaglia R, Swift RM, Leggio L (2017) A Phase I randomized clinical trial testing the safety, tolerability and preliminary pharmacokinetics of the mGluR5 negative allosteric modulator GET 73 following single and repeated doses in healthy volunteers. Eur J Pharm Sci 109:78–85. https://doi.org/10.1016/j.ejps.2017.07.031 PubMedPubMedCentralCrossRef

Hamos JE, Van Horn SC, Raczkowski D, Uhlrich DJ, Sherman SM (1985) Synaptic connectivity of a local circuit neurone in lateral geniculate nucleus of the cat. Nature 317(6038):618–621PubMedCrossRef

Hanson JE, Smith Y (1999) Group I metabotropic glutamate receptors at GABAergic synapses in monkeys. J Neurosci 19(15):6488–6496PubMedCrossRef

Holdefer RN, Norton TT, Godwin DW (1989) Effects of bicuculline on signal detectability in lateral geniculate nucleus relay cells. Brain Res 488(1–2):341–347PubMedCrossRef

Hovelso N, Sotty F, Montezinho LP, Pinheiro PS, Herrik KF, Mork A (2012) Therapeutic potential of metabotropic glutamate receptor modulators. Curr Neuropharmacol 10(1):12–48. https://doi.org/10.2174/157015912799362805 PubMedPubMedCentralCrossRef

Huang YH, Sinha SR, Tanaka K, Rothstein JD, Bergles DE (2004) Astrocyte glutamate transporters regulate metabotropic glutamate receptor-mediated excitation of hippocampal interneurons. J Neurosci 24(19):4551–4559. https://doi.org/10.1523/JNEUROSCI.5217-03.2004 PubMedPubMedCentralCrossRef

Hubert GW, Smith Y (2004) Age-related changes in the expression of axonal and glial group I metabotropic glutamate receptor in the rat substantia nigra pars reticulata. J Comp Neurol 475(1):95–106. https://doi.org/10.1002/cne.20163 PubMedCrossRef

Hubert GW, Paquet M, Smith Y (2001) Differential subcellular localization of mGluR1a and mGluR5 in the rat and monkey substantia nigra. J Neurosci 21(6):1838–1847PubMedPubMedCentralCrossRef

Jaeschke G, Kolczewski S, Spooren W, Vieira E, Bitter-Stoll N, Boissin P, Borroni E, Buttelmann B, Ceccarelli S, Clemann N, David B, Funk C, Guba W, Harrison A, Hartung T, Honer M, Huwyler J, Kuratli M, Niederhauser U, Pahler A, Peters JU, Petersen A, Prinssen E, Ricci A, Rueher D, Rueher M, Schneider M, Spurr P, Stoll T, Tannler D, Wichmann J, Porter RH, Wettstein JG, Lindemann L (2015) Metabotropic glutamate receptor 5 negative allosteric modulators: discovery of 2-chloro-4-[1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]pyridine (basimglurant, RO4917523), a promising novel medicine for psychiatric diseases. J Med Chem 58(3):1358–1371. https://doi.org/10.1021/jm501642c PubMedCrossRef

Johnson KA, Conn PJ, Niswender CM (2009) Glutamate receptors as therapeutic targets for Parkinson’s disease. CNS Neurol Disord 8(6):475–491CrossRef

Johnston TH, Fox SH, McIldowie MJ, Piggott MJ, Brotchie JM (2010) Reduction of L-DOPA-induced dyskinesia by the selective metabotropic glutamate receptor 5 antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson’s disease. J Pharmacol Exp Ther 333(3):865–873. https://doi.org/10.1124/jpet.110.166629 PubMedCrossRef

Jones E (2007) The Thalamus, 2nd edn. Cambridge University Press, Cambridge

Kobayashi S, Nakamura Y (2003) Synaptic organization of the rat parafascicular nucleus, with special reference to its afferents from the superior colliculus and the pedunculopontine tegmental nucleus. Brain Res 980(1):80–91PubMedCrossRef

Kullmann DM, Min MY, Asztely F, Rusakov DA (1999) Extracellular glutamate diffusion determines the occupancy of glutamate receptors at CA1 synapses in the hippocampus. Philos Trans R Soc Lond B Biol Sci 354(1381):395–402. https://doi.org/10.1098/rstb.1999.0392 PubMedPubMedCentralCrossRef

Kuramoto E, Fujiyama F, Nakamura KC, Tanaka Y, Hioki H, Kaneko T (2011) Complementary distribution of glutamatergic cerebellar and GABAergic basal ganglia afferents to the rat motor thalamic nuclei. Eur J Neurosci 33(1):95–109. https://doi.org/10.1111/j.1460-9568.2010.07481.x PubMedCrossRef

Kuwajima M, Hall RA, Aiba A, Smith Y (2004) Subcellular and subsynaptic localization of group I metabotropic glutamate receptors in the monkey subthalamic nucleus. J Comp Neurol 474(4):589–602. https://doi.org/10.1002/cne.20158 PubMedCrossRef

Lacey CJ, Boyes J, Gerlach O, Chen L, Magill PJ, Bolam JP (2005) GABA(B) receptors at glutamatergic synapses in the rat striatum. Neuroscience 136(4):1083–1095. https://doi.org/10.1016/j.neuroscience.2005.07.013 PubMedCrossRef

Landisman CE, Connors BW (2005) Long-term modulation of electrical synapses in the mammalian thalamus. Science 310(5755):1809–1813. https://doi.org/10.1126/science.1114655 PubMedCrossRef

Levandis G, Bazzini E, Armentero MT, Nappi G, Blandini F (2008) Systemic administration of an mGluR5 antagonist, but not unilateral subthalamic lesion, counteracts l-DOPA-induced dyskinesias in a rodent model of Parkinson’s disease. Neurobiol Dis 29(1):161–168. https://doi.org/10.1016/j.nbd.2007.08.011 PubMedCrossRef

Levenga J, Hayashi S, de Vrij FM, Koekkoek SK, van der Linde HC, Nieuwenhuizen I, Song C, Buijsen RA, Pop AS, Gomezmancilla B, Nelson DL, Willemsen R, Gasparini F, Oostra BA (2011) AFQ056, a new mGluR5 antagonist for treatment of fragile X syndrome. Neurobiol Dis 42(3):311–317. https://doi.org/10.1016/j.nbd.2011.01.022 PubMedCrossRef

Lindemann L, Porter RH, Scharf SH, Kuennecke B, Bruns A, von Kienlin M, Harrison AC, Paehler A, Funk C, Gloge A, Schneider M, Parrott NJ, Polonchuk L, Niederhauser U, Morairty SR, Kilduff TS, Vieira E, Kolczewski S, Wichmann J, Hartung T, Honer M, Borroni E, Moreau JL, Prinssen E, Spooren W, Wettstein JG, Jaeschke G (2015) Pharmacology of basimglurant (RO4917523, RG7090), a unique metabotropic glutamate receptor 5 negative allosteric modulator in clinical development for depression. J Pharmacol Exp Ther 353(1):213–233. https://doi.org/10.1124/jpet.114.222463 PubMedCrossRef

Litim N, Morissette M, Di Paolo T (2017) Metabotropic glutamate receptors as therapeutic targets in Parkinson’s disease: an update from the last 5 years of research. Neuropharmacology 115:166–179. https://doi.org/10.1016/j.neuropharm.2016.03.036 PubMedCrossRef

Liu XB, Munoz A, Jones EG (1998) Changes in subcellular localization of metabotropic glutamate receptor subtypes during postnatal development of mouse thalamus. J Comp Neurol 395(4):450–465PubMedCrossRef

Long MA, Landisman CE, Connors BW (2004) Small clusters of electrically coupled neurons generate synchronous rhythms in the thalamic reticular nucleus. J Neurosci 24(2):341–349. https://doi.org/10.1523/JNEUROSCI.3358-03.2004 PubMedPubMedCentralCrossRef

Lorincz ML, Kekesi KA, Juhasz G, Crunelli V, Hughes SW (2009) Temporal framing of thalamic relay-mode firing by phasic inhibition during the alpha rhythm. Neuron 63(5):683–696. https://doi.org/10.1016/j.neuron.2009.08.012 PubMedPubMedCentralCrossRef

Lujan R, Nusser Z, Roberts JD, Shigemoto R, Somogyi P (1996) Perisynaptic location of metabotropic glutamate receptors mGluR1 and mGluR5 on dendrites and dendritic spines in the rat hippocampus. Eur J Neurosci 8(7):1488–1500PubMedCrossRef

Mannaioni G, Marino MJ, Valenti O, Traynelis SF, Conn PJ (2001) Metabotropic glutamate receptors 1 and 5 differentially regulate CA1 pyramidal cell function. J Neurosci 21(16):5925–5934PubMedPubMedCentralCrossRef

Maranis S, Stamatis D, Tsironis C, Konitsiotis S (2012) Investigation of the antidyskinetic site of action of metabotropic and ionotropic glutamate receptor antagonists. Intracerebral infusions in 6-hydroxydopamine-lesioned rats with levodopa-induced dyskinesia. Eur J Pharmacol 683(1–3):71–77. https://doi.org/10.1016/j.ejphar.2012.02.036 PubMedCrossRef

Marino MJ, Wittmann M, Bradley SR, Hubert GW, Smith Y, Conn PJ (2001) Activation of group I metabotropic glutamate receptors produces a direct excitation and disinhibition of GABAergic projection neurons in the substantia nigra pars reticulata. J Neurosci 21(18):7001–7012PubMedPubMedCentralCrossRef

Masilamoni GJ, Smith Y (2018) Metabotropic glutamate receptors: targets for neuroprotective therapies in Parkinson disease. Curr Opin Pharmacol 38:72–80. https://doi.org/10.1016/j.coph.2018.03.004 PubMedPubMedCentralCrossRef

Masilamoni GJ, Bogenpohl JW, Alagille D, Delevich K, Tamagnan G, Votaw JR, Wichmann T, Smith Y (2011) Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys. Brain 134(Pt 7):2057–2073. https://doi.org/10.1093/brain/awr137 PubMedPubMedCentralCrossRef

Mason A, Ilinsky IA, Maldonado S, Kultas-Ilinsky K (2000) Thalamic terminal fields of individual axons from the ventral part of the dentate nucleus of the cerebellum in Macaca mulatta. J Comp Neurol 421(3):412–428PubMedCrossRef

Matelli M, Luppino G, Fogassi L, Rizzolatti G (1989) Thalamic input to inferior area 6 and area 4 in the macaque monkey. J Comp Neurol 280(3):468–488. https://doi.org/10.1002/cne.902800311 PubMedCrossRef

Mela F, Marti M, Dekundy A, Danysz W, Morari M, Cenci MA (2007) Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson’s disease. J Neurochem 101(2):483–497. https://doi.org/10.1111/j.1471-4159.2007.04456.x PubMedCrossRef

Mihov Y, Hasler G (2016) Negative allosteric modulators of metabotropic glutamate receptors subtype 5 in addiction: a therapeutic window. Int J Neuropsychopharmacol 19(7):1–11 pyw002. https://doi.org/10.1093/ijnp/pyw002 CrossRef

Montero VM, Scott GL (1981) Synaptic terminals in the dorsal lateral geniculate nucleus from neurons of the thalamic reticular nucleus: a light and electron microscope autoradiographic study. Neuroscience 6(12):2561–2577PubMedCrossRef

Montero VM, Singer W (1984) Ultrastructure and synaptic relations of neural elements containing glutamic acid decarboxylase (GAD) in the perigeniculate nucleus of the cat. A light and electron microscopic immunocytochemical study. Exp Brain Res 56(1):115–125PubMedCrossRef

Morin N, Gregoire L, Morissette M, Desrayaud S, Gomez-Mancilla B, Gasparini F, Di Paolo T (2013) MPEP, an mGlu5 receptor antagonist, reduces the development of L-DOPA-induced motor complications in de novo parkinsonian monkeys: biochemical correlates. Neuropharmacology 66:355–364. https://doi.org/10.1016/j.neuropharm.2012.07.036 PubMedCrossRef

Morin N, Jourdain VA, Morissette M, Gregoire L, Di Paolo T (2014) Long-term treatment with l-DOPA and an mGlu5 receptor antagonist prevents changes in brain basal ganglia dopamine receptors, their associated signaling proteins and neuropeptides in parkinsonian monkeys. Neuropharmacology 79:688–706. https://doi.org/10.1016/j.neuropharm.2014.01.014 PubMedCrossRef

Morin N, Morissette M, Gregoire L, Di Paolo T (2016) mGlu5, Dopamine D2 and Adenosine A2A Receptors in L-DOPA-induced Dyskinesias. Curr Neuropharmacol 14(5):481–493PubMedPubMedCentralCrossRef

Moss J, Bolam JP (2008) A dopaminergic axon lattice in the striatum and its relationship with cortical and thalamic terminals. J Neurosci 28(44):11221–11230. https://doi.org/10.1523/JNEUROSCI.2780-08.2008 PubMedPubMedCentralCrossRef

Nakanishi S (1994) Metabotropic glutamate receptors: synaptic transmission, modulation, and plasticity. Neuron 13(5):1031–1037PubMedCrossRef

Nicoletti F, Bockaert J, Collingridge GL, Conn PJ, Ferraguti F, Schoepp DD, Wroblewski JT, Pin JP (2011) Metabotropic glutamate receptors: from the workbench to the bedside. Neuropharmacology 60(7–8):1017–1041. https://doi.org/10.1016/j.neuropharm.2010.10.022 PubMedCrossRef

Nicoletti F, Bruno V, Ngomba RT, Gradini R, Battaglia G (2015) Metabotropic glutamate receptors as drug targets: what’s new? Curr Opin Pharmacol 20:89–94. https://doi.org/10.1016/j.coph.2014.12.002 PubMedCrossRef

Niswender CM, Conn PJ (2010) Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu Rev Pharmacol Toxicol 50:295–322. https://doi.org/10.1146/annurev.pharmtox.011008.145533 PubMedPubMedCentralCrossRef

Nusser Z, Mulvihill E, Streit P, Somogyi P (1994) Subsynaptic segregation of metabotropic and ionotropic glutamate receptors as revealed by immunogold localization. Neuroscience 61(3):421–427PubMedCrossRef

Ohara PT, Chazal G, Ralston HJ 3rd (1989) Ultrastructural analysis of GABA-immunoreactive elements in the monkey thalamic ventrobasal complex. J Comp Neurol 283(4):541–558. https://doi.org/10.1002/cne.902830408 PubMedCrossRef

Ossowska K, Konieczny J, Wardas J, Pietraszek M, Kuter K, Wolfarth S, Pilc A (2007) An influence of ligands of metabotropic glutamate receptor subtypes on parkinsonian-like symptoms and the striatopallidal pathway in rats. Amino Acids 32(2):179–188. https://doi.org/10.1007/s00726-006-0317-y PubMedCrossRef

Ottersen OP, Landsend AS (1997) Organization of glutamate receptors at the synapse. Eur J Neurosci 9(11):2219–2224PubMedCrossRef

Ouattara B, Gasparini F, Morissette M, Gregoire L, Samadi P, Gomez-Mancilla B, Di Paolo T (2010) Effect of L-Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys. J Neurochem 113(3):715–724. https://doi.org/10.1111/j.1471-4159.2010.06635.x PubMedCrossRef

Pal B (2018) Involvement of extrasynaptic glutamate in physiological and pathophysiological changes of neuronal excitability. Cell Mol Life Sci 75(16):2917–2949. https://doi.org/10.1007/s00018-018-2837-5 PubMedCrossRef

Paquet M, Smith Y (2003) Group I metabotropic glutamate receptors in the monkey striatum: subsynaptic association with glutamatergic and dopaminergic afferents. J Neurosci 23(20):7659–7669PubMedPubMedCentralCrossRef

Parpura V, Basarsky TA, Liu F, Jeftinija K, Jeftinija S, Haydon PG (1994) Glutamate-mediated astrocyte-neuron signalling. Nature 369(6483):744–747. https://doi.org/10.1038/369744a0 PubMedCrossRef

Parri HR, Gould TM, Crunelli V (2010) Sensory and cortical activation of distinct glial cell subtypes in the somatosensory thalamus of young rats. Eur J Neurosci 32(1):29–40. https://doi.org/10.1111/j.1460-9568.2010.07281.x PubMedPubMedCentralCrossRef

Paxinos G, Huang X-F, Toga A (1999) The rhesus monkey brain in stereotaxic coordinates. Academic Press, San Diego

Perea G, Araque A (2005) Properties of synaptically evoked astrocyte calcium signal reveal synaptic information processing by astrocytes. J Neurosci 25(9):2192–2203. https://doi.org/10.1523/JNEUROSCI.3965-04.2005 PubMedPubMedCentralCrossRef

Peters A, Palay SL, de Webster F (1991) The fine structure of the nervous system: neurons and their supporting cells, vol 2. Oxford University Press, New york

Phillips JM, Lam HA, Ackerson LC, Maidment NT (2006) Blockade of mGluR glutamate receptors in the subthalamic nucleus ameliorates motor asymmetry in an animal model of Parkinson’s disease. Eur J Neurosci 23(1):151–160. https://doi.org/10.1111/j.1460-9568.2005.04550.x PubMedCrossRef

Picconi B, Calabresi P (2014) Targeting metabotropic glutamate receptors as a new strategy against levodopa-induced dyskinesia in Parkinson’s disease? Mov Disord 29(6):715–719. https://doi.org/10.1002/mds.25851 PubMedCrossRef

Pirttimaki TM, Parri HR (2012) Glutamatergic input-output properties of thalamic astrocytes. Neuroscience 205:18–28. https://doi.org/10.1016/j.neuroscience.2011.12.049 PubMedPubMedCentralCrossRef

Pirttimaki TM, Hall SD, Parri HR (2011) Sustained neuronal activity generated by glial plasticity. J Neurosci 31(21):7637–7647. https://doi.org/10.1523/JNEUROSCI.5783-10.2011 PubMedPubMedCentralCrossRef

Poisik OV, Mannaioni G, Traynelis S, Smith Y, Conn PJ (2003) Distinct functional roles of the metabotropic glutamate receptors 1 and 5 in the rat globus pallidus. J Neurosci 23(1):122–130PubMedPubMedCentralCrossRef

Pop AS, Gomez-Mancilla B, Neri G, Willemsen R, Gasparini F (2014) Fragile X syndrome: a preclinical review on metabotropic glutamate receptor 5 (mGluR5) antagonists and drug development. Psychopharmacology 231(6):1217–1226. https://doi.org/10.1007/s00213-013-3330-3 PubMedCrossRef

Pressler RT, Regehr WG (2013) Metabotropic glutamate receptors drive global persistent inhibition in the visual thalamus. J Neurosci 33(6):2494–2506. https://doi.org/10.1523/JNEUROSCI.3458-12.2013 PubMedPubMedCentralCrossRef

Raju DV, Shah DJ, Wright TM, Hall RA, Smith Y (2006) Differential synaptology of vGluT2-containing thalamostriatal afferents between the patch and matrix compartments in rats. J Comp Neurol 499(2):231–243. https://doi.org/10.1002/cne.21099 PubMedPubMedCentralCrossRef

Raju DV, Ahern TH, Shah DJ, Wright TM, Standaert DG, Hall RA, Smith Y (2008) Differential synaptic plasticity of the corticostriatal and thalamostriatal systems in an MPTP-treated monkey model of parkinsonism. Eur J Neurosci 27(7):1647–1658. https://doi.org/10.1111/j.1460-9568.2008.06136.x PubMedCrossRef

Ralston HJ 3rd (1971) Evidence for presynaptic dendrites and a proposal for their mechanism of action. Nature 230(5296):585–587PubMedCrossRef

Rascol O, Fox S, Gasparini F, Kenney C, Di Paolo T, Gomez-Mancilla B (2014) Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias. Parkinsonism Relat Disord 20(9):947–956. https://doi.org/10.1016/j.parkreldis.2014.05.003 PubMedCrossRef

Reilmann R, Rouzade-Dominguez ML, Saft C, Sussmuth SD, Priller J, Rosser A, Rickards H, Schols L, Pezous N, Gasparini F, Johns D, Landwehrmeyer GB, Gomez-Mancilla B (2015) A randomized, placebo-controlled trial of AFQ056 for the treatment of chorea in Huntington’s disease. Mov Disord 30(3):427–431. https://doi.org/10.1002/mds.26174 PubMedCrossRef

Rico AJ, Barroso-Chinea P, Conte-Perales L, Roda E, Gomez-Bautista V, Gendive M, Obeso JA, Lanciego JL (2010) A direct projection from the subthalamic nucleus to the ventral thalamus in monkeys. Neurobiol Dis 39(3):381–392. https://doi.org/10.1016/j.nbd.2010.05.004 PubMedCrossRef

Rodriguez JJ, Garcia DR, Pickel VM (1999) Subcellular distribution of 5-hydroxytryptamine2A and N-methyl-D-aspartate receptors within single neurons in rat motor and limbic striatum. J Comp Neurol 413(2):219–231PubMedCrossRef

Rovo Z, Ulbert I, Acsady L (2012) Drivers of the primate thalamus. J Neurosci 32(49):17894–17908. https://doi.org/10.1523/JNEUROSCI.2815-12.2012 PubMedPubMedCentralCrossRef

Sadikot AF, Parent A, Francois C (1992) Efferent connections of the centromedian and parafascicular thalamic nuclei in the squirrel monkey: a PHA-L study of subcortical projections. J Comp Neurol 315(2):137–159. https://doi.org/10.1002/cne.903150203 PubMedCrossRef

Sakai ST, Inase M, Tanji J (1996) Comparison of cerebellothalamic and pallidothalamic projections in the monkey (Macaca fuscata): a double anterograde labeling study. J Comp Neurol 368(2):215–228. https://doi.org/10.1002/(SICI)1096-9861(19960429)368:2%3c215:AID-CNE4%3e3.0.CO;2-6 PubMedCrossRef

Sakai ST, Stepniewska I, Qi HX, Kaas JH (2000) Pallidal and cerebellar afferents to pre-supplementary motor area thalamocortical neurons in the owl monkey: a multiple labeling study. J Comp Neurol 417(2):164–180PubMedCrossRef

Salt TE, Eaton SA (1996) Functions of ionotropic and metabotropic glutamate receptors in sensory transmission in the mammalian thalamus. Prog Neurobiol 48(1):55–72PubMedCrossRef

Schaeffer E, Pilotto A, Berg D (2014) Pharmacological strategies for the management of levodopa-induced dyskinesia in patients with Parkinson’s disease. CNS Drugs 28(12):1155–1184. https://doi.org/10.1007/s40263-014-0205-z PubMedCrossRef

Sebastianutto I, Cenci MA (2018) mGlu receptors in the treatment of Parkinson’s disease and L-DOPA-induced dyskinesia. Curr Opin Pharmacol 38:81–89. https://doi.org/10.1016/j.coph.2018.03.003 PubMedCrossRef

Sherman SM (2014) The function of metabotropic glutamate receptors in thalamus and cortex. Neuroscientist 20(2):136–149. https://doi.org/10.1177/1073858413478490 PubMedCrossRef

Shigemoto R, Nakanishi S, Mizuno N (1992) Distribution of the mRNA for a metabotropic glutamate receptor (mGluR1) in the central nervous system: an in situ hybridization study in adult and developing rat. J Comp Neurol 322(1):121–135. https://doi.org/10.1002/cne.903220110 PubMedCrossRef

Sillito AM, Kemp JA (1983) The influence of GABAergic inhibitory processes on the receptive field structure of X and Y cells in cat dorsal lateral geniculate nucleus (dLGN). Brain Res 277(1):63–77PubMedCrossRef

Smith Y, Bolam JP (1991) Convergence of synaptic inputs from the striatum and the globus pallidus onto identified nigrocollicular cells in the rat: a double anterograde labelling study. Neuroscience 44(1):45–73PubMedCrossRef

Smith Y, Parent A (1986) Differential connections of caudate nucleus and putamen in the squirrel monkey (Saimiri sciureus). Neuroscience 18(2):347–371PubMedCrossRef

Smith Y, Seguela P, Parent A (1987) Distribution of GABA-immunoreactive neurons in the thalamus of the squirrel monkey (Saimiri sciureus). Neuroscience 22(2):579–591PubMedCrossRef

Smith Y, Charara A, Hanson JE, Paquet M, Levey AI (2000) GABA(B) and group I metabotropic glutamate receptors in the striatopallidal complex in primates. J Anat 196(Pt 4):555–576PubMedPubMedCentralCrossRef

Smith Y, Charara A, Paquet M, Kieval JZ, Pare JF, Hanson JE, Hubert GW, Kuwajima M, Levey AI (2001) Ionotropic and metabotropic GABA and glutamate receptors in primate basal ganglia. J Chem Neuroanat 22(1–2):13–42PubMedCrossRef

Stocchi F, Rascol O, Destee A, Hattori N, Hauser RA, Lang AE, Poewe W, Stacy M, Tolosa E, Gao H, Nagel J, Merschhemke M, Graf A, Kenney C, Trenkwalder C (2013) AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study. Mov Disord 28(13):1838–1846. https://doi.org/10.1002/mds.25561 PubMedCrossRef

Strick PL (1985) How do the basal ganglia and cerebellum gain access to the cortical motor areas? Behav Brain Res 18(2):107–123PubMedCrossRef

Sun W, McConnell E, Pare JF, Xu Q, Chen M, Peng W, Lovatt D, Han X, Smith Y, Nedergaard M (2013) Glutamate-dependent neuroglial calcium signaling differs between young and adult brain. Science 339(6116):197–200. https://doi.org/10.1126/science.1226740 PubMedPubMedCentralCrossRef

Testa CM, Standaert DG, Young AB, Penney JB Jr (1994) Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat. J Neurosci 14(5 Pt 2):3005–3018PubMedCrossRef

Tison F, Keywood C, Wakefield M, Durif F, Corvol JC, Eggert K, Lew M, Isaacson S, Bezard E, Poli SM, Goetz CG, Trenkwalder C, Rascol O (2016) A phase 2A trial of the novel mGluR5-negative allosteric modulator dipraglurant for levodopa-induced dyskinesia in parkinson’s disease. Mov Disord 31(9):1373–1380. https://doi.org/10.1002/mds.26659 PubMedCrossRef

Toyohara J, Sakata M, Oda K, Ishii K, Ito K, Hiura M, Fujinaga M, Yamasaki T, Zhang MR, Ishiwata K (2013) Initial human PET studies of metabotropic glutamate receptor type 1 ligand 11C-ITMM. J Nucl Med 54(8):1302–1307. https://doi.org/10.2967/jnumed.113.119891 PubMedCrossRef

Vaidya A, Jain S, Jain AK, Agrawal A, Kashaw SK, Jain SK, Agrawal RK (2013) Metabotropic glutamate receptors: a review on prospectives and therapeutic aspects. Mini Rev Med Chem 13(13):1967–1981PubMedCrossRef

Varnas K, Jureus A, Finnema SJ, Johnstrom P, Raboisson P, Amini N, Takano A, Stepanov V, Halldin C, Farde L (2018) The metabotropic glutamate receptor 5 radioligand [(11)C]AZD9272 identifies unique binding sites in primate brain. Neuropharmacology 135:455–463. https://doi.org/10.1016/j.neuropharm.2018.03.039 PubMedCrossRef

Verkhratsky A, Orkand RK, Kettenmann H (1998) Glial calcium: homeostasis and signaling function. Physiol Rev 78(1):99–141. https://doi.org/10.1152/physrev.1998.78.1.99 PubMedCrossRef

Viaene AN, Petrof I, Sherman SM (2013) Activation requirements for metabotropic glutamate receptors. Neurosci Lett 541:67–72. https://doi.org/10.1016/j.neulet.2013.02.004 PubMedCrossRef

Wang WW, Zhang XR, Zhang ZR, Wang XS, Chen J, Chen SY, Xie CL (2018) Effects of mGluR5 antagonists on parkinson’s patients with L-dopa-induced dyskinesia: a systematic review and meta-analysis of randomized controlled trials. Front Aging Neurosci 10:262. https://doi.org/10.3389/fnagi.2018.00262 PubMedPubMedCentralCrossRef

Yamasaki T, Maeda J, Fujinaga M, Nagai Y, Hatori A, Yui J, Xie L, Nengaki N, Zhang MR (2014) PET brain kinetics studies of (11)C-ITMM and (11)C-ITDM, radioprobes for metabotropic glutamate receptor type 1, in a nonhuman primate. Am J Nucl Med Mol Imaging 4(3):260–269PubMedPubMedCentral

Youssef EA, Berry-Kravis E, Czech C, Hagerman RJ, Hessl D, Wong CY, Rabbia M, Deptula D, John A, Kinch R, Drewitt P, Lindemann L, Marcinowski M, Langland R, Horn C, Fontoura P, Santarelli L, Quiroz JA, FragXis Study G (2018) Effect of the mGluR5-nam basimglurant on behavior in adolescents and adults with fragile X syndrome in a randomized, double-blind, placebo-controlled trial: fragXis phase 2 results. Neuropsychopharmacology 43(3):503–512. https://doi.org/10.1038/npp.2017.177 PubMedCrossRef

Yung KK, Bolam JP, Smith AD, Hersch SM, Ciliax BJ, Levey AI (1995) Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience 65(3):709–730PubMedCrossRef

Zerbib F, Bruley des Varannes S, Roman S, Tutuian R, Galmiche JP, Mion F, Tack J, Malfertheiner P, Keywood C (2011) Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther 33(8):911–921. https://doi.org/10.1111/j.1365-2036.2011.04596.x PubMedCrossRef

Zhang H, Sulzer D (2003) Glutamate spillover in the striatum depresses dopaminergic transmission by activating group I metabotropic glutamate receptors. J Neurosci 23(33):10585–10592PubMedPubMedCentralCrossRef

Zhang L, Balan G, Barreiro G, Boscoe BP, Chenard LK, Cianfrogna J, Claffey MM, Chen L, Coffman KJ, Drozda SE, Dunetz JR, Fonseca KR, Galatsis P, Grimwood S, Lazzaro JT, Mancuso JY, Miller EL, Reese MR, Rogers BN, Sakurada I, Skaddan M, Smith DL, Stepan AF, Trapa P, Tuttle JB, Verhoest PR, Walker DP, Wright AS, Zaleska MM, Zasadny K, Shaffer CL (2014) Discovery and preclinical characterization of 1-methyl-3-(4-methylpyridin-3-yl)-6-(pyridin-2-ylmethoxy)-1H-pyrazolo-[3,4-b]pyra zine (PF470): a highly potent, selective, and efficacious metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator. J Med Chem 57(3):861–877. https://doi.org/10.1021/jm401622k PubMedCrossRef

Titel: Group I metabotropic glutamate receptors in the primate motor thalamus: subsynaptic association with cortical and sub-cortical glutamatergic afferents
verfasst von: Gunasingh Jeyaraj Masilamoni
Yoland Smith
Publikationsdatum: 17.08.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: Brain Structure and Function / Ausgabe 8/2019
Print ISSN: 1863-2653
Elektronische ISSN: 1863-2661
DOI: https://doi.org/10.1007/s00429-019-01937-2

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Group I metabotropic glutamate receptors in the primate motor thalamus: subsynaptic association with cortical and sub-cortical glutamatergic afferents

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Wartezeit nicht kürzer, aber Arbeit flexibler

„Restriktion auf vier Wochen Therapie bei Schlaflosigkeit ist absurd!“

Stuhltransfusion könnte Fortschreiten von Parkinson-Symptomen bremsen

Frühe Tranexamsäure-Therapie nützt wenig bei Hirnblutungen

Update Neurologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2019

Acute and long-term treadmill running differentially induce c-Fos expression in region- and time-dependent manners in mouse brain

Mapping the landscape of human dopamine D2/3 receptors with [11C]raclopride

Reducing negative affect with anodal transcranial direct current stimulation increases memory performance in young—but not in elderly—individuals

Absolute and relative estimates of genetic and environmental variance in brain structure volumes

Three divisions of the mouse caudal striatum differ in the proportions of dopamine D1 and D2 receptor-expressing cells, distribution of dopaminergic axons, and composition of cholinergic and GABAergic interneurons

The expression of DARPP-32 in adult male zebra finches (Taenopygia guttata)

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Wartezeit nicht kürzer, aber Arbeit flexibler

„Restriktion auf vier Wochen Therapie bei Schlaflosigkeit ist absurd!“

Stuhltransfusion könnte Fortschreiten von Parkinson-Symptomen bremsen

Frühe Tranexamsäure-Therapie nützt wenig bei Hirnblutungen

Update Neurologie